Avidity Biosciences
RNA
#2609
Rank
โ‚ฌ5.11 B
Marketcap
43,28ย โ‚ฌ
Share price
-1.66%
Change (1 day)
755.23%
Change (1 year)

Revenue for Avidity Biosciences (RNA)

Revenue in 2024 (TTM): โ‚ฌ9.83 Million

According to Avidity Biosciences's latest financial reports the company's current revenue (TTM ) is โ‚ฌ9.81 Million. In 2023 the company made a revenue of โ‚ฌ8.64 Million an increase over the revenue in the year 2022 that were of โ‚ฌ8.59 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Avidity Biosciences from 2019 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ9.83 M13.71%
2023 โ‚ฌ8.64 M0.57%
2022 โ‚ฌ8.59 M4.42%
2021 โ‚ฌ8.23 M49.24%
2020 โ‚ฌ5.51 M166.55%
2019 โ‚ฌ2.07 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ0.83 B 8,395.65%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.10 B 991.27%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.39 B 14,099.39%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.40 B 3,999.21%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ11.4 M 16.21%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.10 B 963.91%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ51.54 B 524,874.05%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ37.28 B 379,678.34%๐Ÿ‡ฌ๐Ÿ‡ง UK